URSAPHARM GmbH and Novaliq GmbH announce european partnership agreementANNOUNCE EUROPEAN PARTNERSHIP AGREEMENT

URSAPHARM, one of the leading European companies in the field of ophthalmology, and Novaliq, a clinical stage specialty pharma company with a disruptive drug delivery technology platform focusing on ophthalmology, today jointly announce its partnership agreement as well as the initial European launch of EvoTears™. As part of the agreement, URSAPHARM obtains the exclusive license…